Coronavirus Vaccine Shows Promising Early Results in China

The early-stage trial, published in the Lancet, was conducted by researchers at several laboratories and included 108 participants aged 18 to 60

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus

premium

The researchers in China did find that people who had Ad5 antibodies were less likely to develop a strong immune response to the vaccine

Apoorva Mandavilli | NYT

4 min read Last Updated : May 24 2020 | 12:23 AM IST

A vaccine developed in China appears to be safe and may protect people from the new coronavirus, researchers reported on Friday.

The early-stage trial, published in the Lancet, was conducted by researchers at several laboratories and included 108 participants aged 18 to 60. Those who received a single dose of the vaccine produced certain immune cells, called T cells, within two weeks. Antibodies needed for immunity peaked at 28 days after the inoculation.

“This is promising data, but it’s early data,” said Dr. Dan Barouch, director of vaccine research at Beth Israel Deaconess Medical Center in Boston, who was not involved in

Topics : Coronavirus Vaccine China